Ms Elisavet Angeli

Copenhagen (Denmark)

Membership: HFA Member

Contributor content

$Endotrophin, quantified by a novel assay, is prognostic of all-cause mortality in two different cohorts of patients with heart failure with preserved ejection fraction$

Presentation

Endotrophin, quantified by a novel assay, is prognostic of all-cause mortality in two different cohorts of patients with heart failure with preserved ejection fraction

Presentation

A biomarker of collagen type I is associated with risk of mortality after ST-elevated myocardial infarction

Presentation

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Presentation

Serum PRO-C3, a biomarker of type III collagen formation, is increased in heart failure patients of different aetiologies and can be predictive of outcome

Explore sponsored resources

Ms Elisavet Angeli

Contributor content

Endotrophin, quantified by a novel assay, is prognostic of all-cause mortality in two different cohorts of patients with heart failure with preserved ejection fraction

A biomarker of collagen type I is associated with risk of mortality after ST-elevated myocardial infarction

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Serum PRO-C3, a biomarker of type III collagen formation, is increased in heart failure patients of different aetiologies and can be predictive of outcome

ESC 365 is supported by